US Stock MarketDetailed Quotes

Lyra Therapeutics (LYRA)

Watchlist
  • 0.7106
  • -0.0692-8.87%
15min DelayClose Apr 24 13:14 ET
1.26MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyra Therapeutics (LYRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
58.78%-28.86M
46.56%-6.07M
54.63%-7.36M
67.02%-6.59M
60.62%-8.84M
-10.59%-70.01M
40.43%-11.35M
-14.94%-16.22M
-39.90%-19.98M
-41.67%-22.46M
Net income from continuing operations
69.05%-28.92M
36.69%-6.95M
49.60%-5.98M
84.55%-7.44M
61.93%-8.55M
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
Operating gains losses
---8K
--0
--0
----
----
----
----
----
----
----
Depreciation and amortization
-2.55%459K
-33.77%100K
166.67%104K
-12.41%127K
-5.88%128K
69.42%471K
77.65%151K
157.35%39K
730.43%145K
-52.11%136K
Change In working capital
57.04%-2.73M
110.15%223K
72.35%-1.52M
-106.90%-186K
8.77%-1.25M
-29.91%-6.35M
49.87%-2.2M
-549.10%-5.48M
380.65%2.7M
-79.29%-1.37M
-Change in prepaid assets
644.47%2.07M
58.11%585K
135.75%315K
129.64%891K
208.17%278K
-143.83%-380K
22.52%370K
-54.56%-881K
32.88%388K
-130.49%-257K
-Change in payables and accrued expense
70.40%-2.33M
86.67%-225K
80.66%-1.06M
74.03%-247K
-397.00%-793K
-505.05%-7.86M
-18.96%-1.69M
-277.15%-5.49M
-32.82%-951K
-72.67%267K
-Change in other current assets
27.11%3.13M
0.00%783K
128.28%783K
-50.82%784K
405.47%782K
150.01%2.46M
128.30%783K
178.67%343K
391.98%1.59M
87.50%-256K
-Change in other current liabilities
-638.51%-5.2M
37.12%-913K
-305.11%-1.53M
-163.21%-1.43M
-125.76%-1.33M
179.97%966K
-313.68%-1.45M
326.14%744K
661.79%2.26M
-372.00%-590K
-Change in other working capital
74.05%-398K
96.65%-7K
87.18%-25K
69.40%-183K
65.60%-183K
1.54%-1.53M
-43.15%-209K
64.15%-195K
-30.57%-598K
-29.76%-532K
Cash from discontinued investing activities
Operating cash flow
58.78%-28.86M
46.56%-6.07M
54.63%-7.36M
67.02%-6.59M
60.62%-8.84M
-10.59%-70.01M
40.43%-11.35M
-14.94%-16.22M
-39.90%-19.98M
-41.67%-22.46M
Investing cash flow
Cash flow from continuing investing activities
-100.12%-98K
-100.34%-96K
0
-100.01%-2K
0
738.15%80.31M
1,292.50%28.13M
154.35%8.14M
6,548.48%36.18M
47.83%7.86M
Net PPE purchase and sale
95.81%-98K
-265.52%-96K
--0
98.98%-2K
--0
-123.30%-2.34M
107.37%58K
64.58%-51K
-176.06%-196K
-4,675.56%-2.15M
Net investment purchase and sale
--0
--0
--0
--0
--0
816.33%82.64M
1,885.81%28.07M
155.22%8.19M
7,522.86%36.37M
86.68%10.01M
Cash from discontinued investing activities
Investing cash flow
-100.12%-98K
-100.34%-96K
--0
-100.01%-2K
--0
738.15%80.31M
1,292.50%28.13M
154.35%8.14M
6,548.48%36.18M
47.83%7.86M
Financing cash flow
Cash flow from continuing financing activities
-49.91%4.27M
0
-1,500.00%-368K
5,314.61%4.64M
0
-87.01%8.53M
-100.01%-1K
94.50%-23K
-100.19%-89K
216,000.00%8.64M
Net common stock issuance
-43.31%5M
--0
--0
----
----
-87.26%8.82M
-100.01%-1K
--0
----
----
Net preferred stock issuance
----
----
----
----
--0
----
----
----
----
--8.81M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
-97.09%3K
--0
--0
--0
-25.00%3K
Net other financing activities
-150.34%-726K
--0
-1,500.00%-368K
----
----
92.06%-290K
--0
94.52%-23K
---98K
---169K
Cash from discontinued financing activities
Financing cash flow
-49.91%4.27M
--0
-1,500.00%-368K
5,314.61%4.64M
--0
-87.01%8.53M
-100.01%-1K
94.50%-23K
-100.19%-89K
216,000.00%8.64M
Net cash flow
Beginning cash position
79.28%42.57M
-6.76%24.05M
-6.25%31.78M
89.58%33.73M
79.28%42.57M
-30.04%23.75M
-1.71%25.79M
-39.20%33.9M
-24.01%17.79M
-30.04%23.75M
Current changes in cash
-231.12%-24.68M
-136.73%-6.16M
4.64%-7.73M
-112.11%-1.95M
-48.51%-8.84M
284.61%18.83M
771.93%16.78M
72.54%-8.11M
-50.20%16.11M
43.46%-5.95M
End cash Position
-57.98%17.89M
-57.98%17.89M
-6.76%24.05M
-6.25%31.78M
89.58%33.73M
79.28%42.57M
79.28%42.57M
-1.71%25.79M
-39.20%33.9M
-24.01%17.79M
Free cash flow
59.95%-28.98M
45.44%-6.16M
54.77%-7.36M
67.24%-6.61M
64.06%-8.84M
-12.43%-72.35M
43.09%-11.29M
-14.14%-16.27M
-40.58%-20.18M
-54.79%-24.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 58.78%-28.86M46.56%-6.07M54.63%-7.36M67.02%-6.59M60.62%-8.84M-10.59%-70.01M40.43%-11.35M-14.94%-16.22M-39.90%-19.98M-41.67%-22.46M
Net income from continuing operations 69.05%-28.92M36.69%-6.95M49.60%-5.98M84.55%-7.44M61.93%-8.55M-49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M
Operating gains losses ---8K--0--0----------------------------
Depreciation and amortization -2.55%459K-33.77%100K166.67%104K-12.41%127K-5.88%128K69.42%471K77.65%151K157.35%39K730.43%145K-52.11%136K
Change In working capital 57.04%-2.73M110.15%223K72.35%-1.52M-106.90%-186K8.77%-1.25M-29.91%-6.35M49.87%-2.2M-549.10%-5.48M380.65%2.7M-79.29%-1.37M
-Change in prepaid assets 644.47%2.07M58.11%585K135.75%315K129.64%891K208.17%278K-143.83%-380K22.52%370K-54.56%-881K32.88%388K-130.49%-257K
-Change in payables and accrued expense 70.40%-2.33M86.67%-225K80.66%-1.06M74.03%-247K-397.00%-793K-505.05%-7.86M-18.96%-1.69M-277.15%-5.49M-32.82%-951K-72.67%267K
-Change in other current assets 27.11%3.13M0.00%783K128.28%783K-50.82%784K405.47%782K150.01%2.46M128.30%783K178.67%343K391.98%1.59M87.50%-256K
-Change in other current liabilities -638.51%-5.2M37.12%-913K-305.11%-1.53M-163.21%-1.43M-125.76%-1.33M179.97%966K-313.68%-1.45M326.14%744K661.79%2.26M-372.00%-590K
-Change in other working capital 74.05%-398K96.65%-7K87.18%-25K69.40%-183K65.60%-183K1.54%-1.53M-43.15%-209K64.15%-195K-30.57%-598K-29.76%-532K
Cash from discontinued investing activities
Operating cash flow 58.78%-28.86M46.56%-6.07M54.63%-7.36M67.02%-6.59M60.62%-8.84M-10.59%-70.01M40.43%-11.35M-14.94%-16.22M-39.90%-19.98M-41.67%-22.46M
Investing cash flow
Cash flow from continuing investing activities -100.12%-98K-100.34%-96K0-100.01%-2K0738.15%80.31M1,292.50%28.13M154.35%8.14M6,548.48%36.18M47.83%7.86M
Net PPE purchase and sale 95.81%-98K-265.52%-96K--098.98%-2K--0-123.30%-2.34M107.37%58K64.58%-51K-176.06%-196K-4,675.56%-2.15M
Net investment purchase and sale --0--0--0--0--0816.33%82.64M1,885.81%28.07M155.22%8.19M7,522.86%36.37M86.68%10.01M
Cash from discontinued investing activities
Investing cash flow -100.12%-98K-100.34%-96K--0-100.01%-2K--0738.15%80.31M1,292.50%28.13M154.35%8.14M6,548.48%36.18M47.83%7.86M
Financing cash flow
Cash flow from continuing financing activities -49.91%4.27M0-1,500.00%-368K5,314.61%4.64M0-87.01%8.53M-100.01%-1K94.50%-23K-100.19%-89K216,000.00%8.64M
Net common stock issuance -43.31%5M--0--0---------87.26%8.82M-100.01%-1K--0--------
Net preferred stock issuance ------------------0------------------8.81M
Proceeds from stock option exercised by employees --0--0--0--0--0-97.09%3K--0--0--0-25.00%3K
Net other financing activities -150.34%-726K--0-1,500.00%-368K--------92.06%-290K--094.52%-23K---98K---169K
Cash from discontinued financing activities
Financing cash flow -49.91%4.27M--0-1,500.00%-368K5,314.61%4.64M--0-87.01%8.53M-100.01%-1K94.50%-23K-100.19%-89K216,000.00%8.64M
Net cash flow
Beginning cash position 79.28%42.57M-6.76%24.05M-6.25%31.78M89.58%33.73M79.28%42.57M-30.04%23.75M-1.71%25.79M-39.20%33.9M-24.01%17.79M-30.04%23.75M
Current changes in cash -231.12%-24.68M-136.73%-6.16M4.64%-7.73M-112.11%-1.95M-48.51%-8.84M284.61%18.83M771.93%16.78M72.54%-8.11M-50.20%16.11M43.46%-5.95M
End cash Position -57.98%17.89M-57.98%17.89M-6.76%24.05M-6.25%31.78M89.58%33.73M79.28%42.57M79.28%42.57M-1.71%25.79M-39.20%33.9M-24.01%17.79M
Free cash flow 59.95%-28.98M45.44%-6.16M54.77%-7.36M67.24%-6.61M64.06%-8.84M-12.43%-72.35M43.09%-11.29M-14.14%-16.27M-40.58%-20.18M-54.79%-24.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -